Survey of State Medicaid Drug Programs Finds Sharpened Focus on Costs and Value
14th Nov 2006, 18:54 GMT
Recent Federal Program Changes in Medicaid and Medicare Have Not Alleviated Financial Pressure
Survey of State Medicaid Drug Programs Finds Sharpened Focus on Costs and Value related news:
- Disease Management Programs Can Help Improve the Health of Medicaid Patients Through Improved Care Coordination While Helping To Control Medicaid Costs — RedOrbit News - Health
- Doctors Rarely Discuss Drug Costs With Patients — KeepMedia: KeepMedia Home
- BC/BS of MI, Blue Care Network Gear Up to Offer 2007 Medicare Advantage and Part D Prescription Drug Programs — Medicare/ Medicaid News from StratCenter.com
- $1.2 Million Recovered in Medicaid Fraud Settlement with Omnicare — Kansas City infoZine Business Headlines
- Survey Profiles Student Drug Use — TheDay.Com - Educational News
- Nixon recovers more than $1.2 million in Medicaid fraud settlement with Omnicare — Missouri Attorney General's Office News
- ICON issues Survey of Nanotechnology Practices — EurekAlert! - Chemistry, Physics and Materials Sciences
- Federal monitor finds almost $43 million misspent at N.J. med school — SignOnSanDiego.com: Nation
- Intesource Announces a New, No Risk Offer to Lower Pharmaceutical Costs — RedOrbit News - Health
- Survey: British girls have sex earlier — United Press International - NewsTrack
Latest news from Pharmaceuticals News from StratCenter.com:
- Spectrum Pharmaceuticals to Receive $5 mln Milestone Payment From PAR Pharmaceutical for Sumatriptan Injection
- Medco to Present at the Credit Suisse Annual Healthcare Conference
- Bob Dole Medicare Podcast Helps Seniors through 2007 Drug Coverage Enrollment Process
- Unique Sugar Improves Energy, Pain and Quality of Life in Fibromyalgia and Chronic Fatigue Patients!
- Care Clinic Purchases Pinnacle Easy Care
- Pegasystems Enhances 2 Business Critical BPM Frameworks for the Healthcare Industry
- Isis Cholesterol Drug Shown Effective
- Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
- Nymox Reports Q3 2006 Financial Results
- RemoteMDx Raises $6 mln in Private Placement